Legal & General Group
SLS icon

Legal & General Group’s SELLAS Life Sciences SLS Stock Holding History

Legal & General Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
167,800
+152,658
+1,008% +$1.05M ﹤0.01% 1886
2026
Q1 		$64.1K Buy
15,142
+2,110
+16% +$9.44K ﹤0.01% 2645
2025
Q4 		$49.1K Buy
13,032
+2,406
+23% +$4.68K ﹤0.01% 2730
2025
Q3 		$17.1K Hold
10,626
– – ﹤0.01% 3109
2025
Q2 		$23.3K Buy
+10,626
New +$16.3K ﹤0.01% 2947
2017
Q2 		– Sell
-1
Closed -$1K – 3378
2017
Q1 		$1K Hold
1
– – ﹤0.01% 3262
2016
Q4 		$2K Buy
+1
New +$5.82K ﹤0.01% 3282

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Legal & General Group's SLS Position: Q2 2026 in Review

Legal & General Group increased its SELLAS Life Sciences (SLS) stake by 1,008% in Q2 2026, buying an estimated $1.05M and bringing the position to 167,800 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Legal & General Group first reported a position in SLS in Q4 2016 and has held it in 7 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Legal & General Group held 167,800 shares of SELLAS Life Sciences worth $2.48M as of Q2 2026.
  • Legal & General Group bought 152,658 SELLAS Life Sciences shares in Q2 2026, an estimated $1.05M.
  • SELLAS Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1886 holding.
  • Legal & General Group first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 7 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.